SG Americas Securities Reduces Stake in Ingevity Corporation

Investment firm cuts holdings in specialty chemicals company by over 60%

Apr. 13, 2026 at 8:54am

Got story updates? Submit your updates here. ›

A high-contrast, black and white close-up photograph of complex industrial machinery and equipment, conveying the heavy-duty, technical nature of the specialty chemicals industry.An intimate look at the industrial processes powering Ingevity's specialty chemical operations.North Charleston Today

SG Americas Securities LLC, an investment management firm, has reduced its stake in Ingevity Corporation (NYSE: NGVT) by 61% during the fourth quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 8,615 shares of the specialty chemicals company, valued at $510,000.

Why it matters

This transaction reflects changes in SG Americas Securities' investment strategy and portfolio composition. Ingevity, a manufacturer of specialty chemicals and performance materials, has seen its stock price fluctuate in recent quarters, making it an interesting investment target for institutional investors.

The details

According to the 13F filing, SG Americas Securities sold 13,475 shares of Ingevity during the fourth quarter, reducing its total holdings to 8,615 shares. The firm's previous stake in the company was valued at $1.3 million. Ingevity's stock price has ranged from $30.19 to $77.46 over the past 52 weeks, reflecting the volatility in the specialty chemicals sector.

  • SG Americas Securities filed the 13F report on April 13, 2026, disclosing its Q4 2025 holdings.
  • The firm reduced its Ingevity stake during the fourth quarter of 2025.

The players

SG Americas Securities LLC

An investment management firm that has reduced its stake in Ingevity Corporation.

Ingevity Corporation

A specialty chemicals and performance materials company headquartered in North Charleston, South Carolina.

Got photos? Submit your photos here. ›

The takeaway

This transaction highlights the ongoing shifts in institutional investment strategies, as firms adjust their portfolios to adapt to market conditions and emerging trends in the specialty chemicals industry.